COMMUNIQUÉS West-GlobeNewswire
-
Nyxoah Accueille la Fédération Flamande des Investisseurs (VFB) à LégiaPark à la Suite des Résultats du Premier Trimestre 2026 et de la Dynamique Commerciale aux États-Unis
20/05/2026 -
Strongest Phentermine Alternatives 2026: What OTC Options Are Commonly Compared to Phentermine? PhenQ Formulation Assessment Using the SCALE-9 Evaluation Model
20/05/2026 -
Cytokinetics to Hold Annual Meeting of Stockholders
20/05/2026 -
Vivos Therapeutics Reports First Quarter 2026 Financial Results and Provides Operational Update
20/05/2026 -
Cellectis’ Annual Shareholders General Meeting to be Held on June 25, 2026
20/05/2026 -
Johns Hopkins Health Plans Awards $60,000 to Maryland and Virginia Organizations
20/05/2026 -
Corvus Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference and Goldman Sachs 47th Annual Global Healthcare Conference
20/05/2026 -
Nanobiotix Announces Launch of Global Follow-On Offering
21/05/2026 -
Rapport Therapeutics to Participate in the Jefferies Global Healthcare Conference and Goldman Sachs 47th Annual Global Healthcare Conference
20/05/2026 -
FDA Warns Retailers Selling Illegal Tobacco Products That Look Like Everyday Products
20/05/2026 -
AIM ImmunoTech Announces $2.4 Million Financing, Including Concurrent Registered Direct Offering and Private Placement
20/05/2026 -
Jupiter Neurosciences Announces Pricing of $2.0 Million Registered Direct Offering
20/05/2026 -
Ronald McDonald House New England Launches Brand Revitalization, Deepening its Mission to Keep Families Close
20/05/2026 -
How To Boost Testosterone After 40?| Safe Testosterone Boosters for Men Over 40 and 50 For Muscle Growth, Energy, Stamina and Performance in 2026 – Launched By Testoprime
20/05/2026 -
MiNK Therapeutics Reports New Data on agenT-797, an allo-iNKT Cell Therapy at ATS 2026; Simultaneously Published in Clinical Immunology Communications
20/05/2026 -
IRADIMED CORPORATION to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
20/05/2026 -
Stablecoin Development Corporation Reports First Quarter 2026 Financial Results
20/05/2026 -
Propanc Biopharma’s CEO Forecasts New Medical Breakthroughs in the Fight Against Pancreatic Cancer Over the Next Decade
20/05/2026 -
Ernexa Therapeutics Releases Virtual Investor KOL Connect Segment Featuring Dr. Elena Ratner Highlighting Ovarian Cancer Landscape and ERNA-101 Opportunity
20/05/2026
Pages